Fragile X premutation carrier screening in Pakistani preconception women in primary care consultation

BMC Womens Health. 2022 Mar 4;22(1):57. doi: 10.1186/s12905-022-01632-1.

Abstract

Purpose: Women of reproductive age who carry fragile X premutation (PM) alleles have 56 to 200 CGG repeats in the 5'-untranslated region of FMR1 gene are at increased risk for producing children with intellectual disabilities (ID) or autism spectrum disorders (ASD) due to expansion of PM alleles to full mutation alleles (> 200 repeats) during maternal transmission.

Methods: In present study fragile X PM carrier screening was performed in total 808 women who were consulting primary health care centers for preconception care in Khyber Pakhtunkhwa region of Pakistan between April, 2018 and December, 2020. Polymerase chain reaction (PCR) was performed for detection of PM carrier women and the CGG repeats number was confirmed by Southern blotting and capillary electrophoresis.

Results: The prevalence rate for PM carriers among preconception women was found to be 0.7% that was contributed by 0.5% women in risk group (RG1) with family history of ID and 0.2% in risk group 2 (RG2) with family history of ASD. PM carrier women had at least one affected child or sibling. In addition, the preconception women with FMR1 PM alleles were found to be at increased risk for primary ovary insufficiency (RG1: P = 0.0265, RG2: P = 0.0389), postpartum depression (RG1: P = 0.0240, RG2: P = 0.0501) and neuropsychiatric disorders (RG1: P = 0.0389, RG2: P = 0.0432).

Conclusions: Current study provides first evidence of fragile X PM carrier screening in Pakistani preconception women in primary care consultation. Findings of current study may help to improve preconception care and to reduce burden of fragile X associated disorders in our population.

Keywords: FMR1; Fragile X associated disorders; PM carrier screening; Pakistani preconception women; Risk groups.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Female
  • Fragile X Mental Retardation Protein* / genetics
  • Fragile X Syndrome* / diagnosis
  • Fragile X Syndrome* / epidemiology
  • Fragile X Syndrome* / genetics
  • Humans
  • Male
  • Mutation
  • Pakistan
  • Primary Health Care
  • Referral and Consultation

Substances

  • FMR1 protein, human
  • Fragile X Mental Retardation Protein